arrow
Return

Novel 1-Phenyl-2; 3-dihydroquinazolin-4(1H)-one Derivatives as Nav 1.8 Voltage-Gated Sodium Channels Inhibitors

delete2026-04-22
delete0
delete
OA
AI
R
Ruihu Song
S
Steven H. Liang *
DOI:10.1021/acsmedchemlett.6c00189delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
This highlight outlines the development of novel substituted 1-phenyl-2,3-dihydroquinazolin-4(1H)-one derivatives as potential inhibitor candidates for Nav 1.8 voltage-gated sodium channels (Nav 1.8), which is upregulated or activated to transmit nociceptive signaling in a range of pain-related disorders. The invention includes details on preparation methods, biological activity assays, and pharmaceutical compositions.
Keywords:
1-Phenyl-2,3-dihydroquinazolin-4(1H)-one
Nav 1.8
voltage-gated sodium channels
pain-related disorders
inhibitor candidates

Journal

ACS Medicinal Chemistry Letters cover
ACS Medicinal Chemistry Letters
IF:
4
Papers:
4.4K
Citations:
10.0K

Organization

E
Emory University
Scholars:
5.0W
Papers: 4.2W
Citations: 5.7W